About

Executive Chairman of the board since August 2020. Former President and CEO of Gilead Sciences (2016-2019) after 29 years at Gilead. Serves on the boards of Pacific Biosciences of California and Kailera Therapeutics.

Roles

4D Molecular Therapeutics, Inc.
Director and Executive Chairman · Current role
2020–present

Director Compensation

FY 2025
Fees earned or paid in cash
$150,000
Option awards
$105,000
Total
$255,000

Also at 4D Molecular Therapeutics, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.